"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."

Margaret Mead
Editorial
peer-reviewed

To Dab or Not to Dab: Rising Concerns Regarding the Toxicity of Cannabis Concentrates



Abstract

Cannabis use is steadily rising in the United States. As the popularity of marijuana rises, new varieties of cannabis-related products are becoming available. Dabs are cannabis concentrates gaining notoriety for their significant amounts of tetrahydrocannabinol (THC) that are ultimately vaporized and inhaled for their effect. Herein, we provide an overview of recent cases of dabbing to bring awareness to the clinicians, of the significant adverse effects associated with dabs including psychosis, neurotoxicity, and cardiotoxicity.



Want to read more?

Create a free account to continue reading this article.

Already a member? Login.



Editorial
peer-reviewed

To Dab or Not to Dab: Rising Concerns Regarding the Toxicity of Cannabis Concentrates


Author Information

Saeed K. Alzghari

Gulfstream Genomics, Gulfstream Diagnostics

Victor Fung

Department of Emergency Medicine, Parkland Health and Hospital System, Dallas Texas

Shannon S. Rickner

Department of Emergency Medicine, UT Southwestern Medical Center

Liza Chacko

Reference Health Laboratories, Gulfstream Diagnostics

Steven W. Fleming Corresponding Author

Reference Health Laboratories, Gulfstream Diagnostics


Ethics Statement and Conflict of Interest Disclosures

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: Saeed K. Alzghari, Liza Chacko, and Steven W. Fleming declare(s) employment from Gulfstream Diagnostics. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.


Editorial
peer-reviewed

To Dab or Not to Dab: Rising Concerns Regarding the Toxicity of Cannabis Concentrates


Figures etc.

Share
Editorial
peer-reviewed

To Dab or Not to Dab: Rising Concerns Regarding the Toxicity of Cannabis Concentrates

Saeed K. Alzghari">Saeed K. Alzghari, Victor Fung">Victor Fung, Shannon S. Rickner">Shannon S. Rickner, Liza Chacko">Liza Chacko, Steven W. Fleming">Steven W. Fleming

  • Author Information
    Saeed K. Alzghari

    Gulfstream Genomics, Gulfstream Diagnostics

    Victor Fung

    Department of Emergency Medicine, Parkland Health and Hospital System, Dallas Texas

    Shannon S. Rickner

    Department of Emergency Medicine, UT Southwestern Medical Center

    Liza Chacko

    Reference Health Laboratories, Gulfstream Diagnostics

    Steven W. Fleming Corresponding Author

    Reference Health Laboratories, Gulfstream Diagnostics


    Ethics Statement and Conflict of Interest Disclosures

    Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: Saeed K. Alzghari, Liza Chacko, and Steven W. Fleming declare(s) employment from Gulfstream Diagnostics. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

    Acknowledgements


    Article Information

    Published: September 11, 2017

    DOI

    10.7759/cureus.1676

    Cite this article as:

    Alzghari S K, Fung V, Rickner S S, et al. (September 11, 2017) To Dab or Not to Dab: Rising Concerns Regarding the Toxicity of Cannabis Concentrates. Cureus 9(9): e1676. doi:10.7759/cureus.1676

    Publication history

    Received by Cureus: August 25, 2017
    Peer review began: September 05, 2017
    Peer review concluded: September 07, 2017
    Published: September 11, 2017

    Copyright

    © Copyright 2017
    Alzghari et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 3.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

    License

    This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Cannabis use is steadily rising in the United States. As the popularity of marijuana rises, new varieties of cannabis-related products are becoming available. Dabs are cannabis concentrates gaining notoriety for their significant amounts of tetrahydrocannabinol (THC) that are ultimately vaporized and inhaled for their effect. Herein, we provide an overview of recent cases of dabbing to bring awareness to the clinicians, of the significant adverse effects associated with dabs including psychosis, neurotoxicity, and cardiotoxicity.



Want to read more?

Create a free account to continue reading this article.

Already a member? Login.



Saeed K. Alzghari, M.S., M.B.A. (HOM), Pharm.D., BCPS

Gulfstream Genomics, Gulfstream Diagnostics

Victor Fung, B.Sc.

Department of Emergency Medicine, Parkland Health and Hospital System, Dallas Texas

Shannon S. Rickner

Department of Emergency Medicine, UT Southwestern Medical Center

Liza Chacko

Reference Health Laboratories, Gulfstream Diagnostics

Steven W. Fleming, M.Sc.

Reference Health Laboratories, Gulfstream Diagnostics

For correspondence:
sfleming@gulfdiagnostics.com

Saeed K. Alzghari, M.S., M.B.A. (HOM), Pharm.D., BCPS

Gulfstream Genomics, Gulfstream Diagnostics

Victor Fung, B.Sc.

Department of Emergency Medicine, Parkland Health and Hospital System, Dallas Texas

Shannon S. Rickner

Department of Emergency Medicine, UT Southwestern Medical Center

Liza Chacko

Reference Health Laboratories, Gulfstream Diagnostics

Steven W. Fleming, M.Sc.

Reference Health Laboratories, Gulfstream Diagnostics

For correspondence:
sfleming@gulfdiagnostics.com